PHARMACEUTICAL ENTERPRISES' MARKET ENTRY STRATEGIES

被引:0
|
作者
Araja, Diana [1 ]
Sumilo, Erika [2 ]
机构
[1] Riga Stradins Univ, Riga, Latvia
[2] Univ Latvia, Riga, Latvia
关键词
market entry strategy; pharmaceutical enterprise; Managed Entry Agreements;
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
The pharmaceutical sector encompasses a wide range of business activities - research and product development, manufacturing, marketing, international business, wholesale, retail and services. Consequently, it is facing the contemporary challenges of globalisation, sustainable development, social, economic and political change. At the same time, pharmaceuticals have a significant impact on the provision of health care, which limits the freedom of business. In framework of this research the applicability of the International business theories to pharmaceutical sector, as well as the major factors influencing the enterprise' choice of the market entry mode are explored. The organisation of healthcare and its financing system are important external factors influencing the market entry strategy of the pharmaceutical company. Focusing on the healthcare market as a platform for medical entrepreneurship and significant regulatory interventions, it should be noted that, in a context of globalization, healthcare is characterised as both an international business and an area to strong government influence and demand generation. In the process of market entry strategy development, pharmaceutical enterprises more often choose the direct exporting, contractual modes and foreign direct investments as the market entry modes. In these circumstances, the Managed Entry Agreements become topical to ensure the availability of new medicines for patients and to encourage the pharmaceutical enterprises to come into market.
引用
下载
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [21] Striving for an Optimal Entry into the Chemical & Pharmaceutical Job Market
    Dubey, Romain
    Gimpel, Andreas
    Zouboulis, Konstantin
    Bocker, Markus
    CHIMIA, 2020, 74 (09) : 737 - 738
  • [22] STRATEGIES OF ENTERPRISES IN THE GERMAN LABOR-MARKET
    WINDOLF, P
    CAMBRIDGE JOURNAL OF ECONOMICS, 1981, 5 (04) : 351 - 367
  • [23] Market Entry, Political Relationship and Financing Constrain of Private Enterprises
    Li Li
    Che Jing
    Xue Donghui
    PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON CORPORATE GOVERNANCE, 2011, : 193 - 200
  • [24] The influence of liability of foreignness on market entry strategies
    Chen, Haiyang
    Griffith, David A.
    Hu, Michael Y.
    INTERNATIONAL MARKETING REVIEW, 2006, 23 (06) : 636 - 649
  • [25] Foreign market entry strategies of Japanese MNCs
    Taylor, CR
    Zou, SM
    Osland, GE
    INTERNATIONAL MARKETING REVIEW, 2000, 17 (2-3) : 146 - 163
  • [26] Strategies That Delay Market Entry of Generic Drugs
    Vokinger, Kerstin Noelle
    Kesselheim, Aaron S.
    Avorn, Jerry
    Sarpatwari, Ameet
    JAMA INTERNAL MEDICINE, 2017, 177 (11) : 1665 - 1669
  • [27] Market entry strategies of small automotive suppliers
    Kasouf, CJ
    Celuch, KG
    Nigam, S
    INNOVATION IN TECHNOLOGY MANAGEMENT - THE KEY TO GLOBAL LEADERSHIP: THE KEY TO GLOBAL LEADERSHIP, 1997, : 94 - 97
  • [28] Multinational enterprises' Entry Mode Strategies and Uncertainty: A Review and Extension
    Ahsan, Mujtaba
    Musteen, Martina
    INTERNATIONAL JOURNAL OF MANAGEMENT REVIEWS, 2011, 13 (04) : 376 - 392
  • [29] Foreign Market Entry Strategies under Asymmetric Information
    Nastasi, Alberto
    Reverberi, Pierfrancesco
    REVIEW OF INTERNATIONAL ECONOMICS, 2007, 15 (04) : 758 - 781
  • [30] COMPETITIVE STRATEGIES FOR LATE ENTRY INTO A MARKET WITH A DOMINANT BRAND
    CARPENTER, GS
    NAKAMOTO, K
    MANAGEMENT SCIENCE, 1990, 36 (10) : 1268 - 1278